Wordt geladen...
Targeting the Kaposi’s sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells
BACKGROUND: Kaposi’s sarcoma-associated herpesvirus (KSHV) is a transforming gammaherpesvirus. Like other herpesviruses, KSHV infection is for life long and there is no treatment that can cure patients from the virus. In addition, there is an urgent need to target viral genes to study their role dur...
Bewaard in:
| Gepubliceerd in: | Virol J |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7966637/ https://ncbi.nlm.nih.gov/pubmed/33731154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-021-01527-x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|